Cheaper, more accessible cell, gene therapies? Nobel winner's task force points the way.
As more gene and cell therapies work their way through clinical trials — and some, like BioMarin's hemophilia A gene therapy costing millions of dollars — now is the time to look at new ways to develop, manufacturing and pay for those treatments, a task force says.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Clinical Trials | Gene Therapy | Genetics | Haemophilia | Health Management | Hemophilia | Pharmaceuticals